Author

Andreas Oder

Leibniz-Forschungsinstitut für Molekulare PharmakologieORCID 0009-0004-9852-3818Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:cryo-EM· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Jens Peter von KriesiD· 3 shared Martin NeuenschwanderiD· 2 shared Alexander HerrmanniD· 1 shared Andrei N. LupasiD· 1 shared Birte Hernandez AlvareziD· 1 shared Christopher HeimiD· 1 shared Daniel RodereriD· 1 shared Edgar SpeckeriD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Jens Peter von KriesORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivPreprintOct 11, 2026

Cereblon on Steroids: Beyond the Canonical Ligand Space

Alexander Herrmann, Christopher Heim, Samuel A. Maiwald…·Marcus D. Hartmann

This paper expands the known ligand space of Cereblon by identifying new chemically distinct ligands that bind through non-canonical mechanisms.

DOI 10.64898/2026.08.28.747849

humanexperimental assay

𝕏 PostBluesky

BiophysicsProceedings of the National Academy of SciencesPeer-reviewedApr 8, 2025

Structural basis for immune cell binding of Fusobacterium nucleatum via the trimeric autotransporter adhesin CbpF

Gian Luca Marongiu, Uwe Fink, Felix Schöpf…·Daniel Roderer

This study presents the first structural description of the fusobacterial TAA CbpF and its interaction with CEACAM1, revealing a novel binding mode and potential targets for drug design in CRC.

9 citations

𝕏 PostBluesky

BiochemistryPLoS ONEPeer-reviewedJul 29, 2024

Identification of drug-like molecules targeting the ATPase activity of dynamin-like EHD4

Saif Mohd, Andreas Oder, Edgar Specker…·Oliver Daumke

The paper identifies a drug-like molecule that inhibits EHD4's liposome-stimulated ATPase activity and provides SAR insights for improved inhibitor design.

2 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky